Used in pharmaceutical and biochemical research as a derivative to study glucuronidation pathways, a key detoxification mechanism in the liver. Acts as a substrate or inhibitor in enzymatic assays involving β-glucuronidase. Also explored in prodrug design, where the phenylpropyl group may enhance lipophilicity and membrane permeability, allowing targeted release of active compounds after enzymatic cleavage. Shows potential in improving drug delivery and bioavailability of conjugated therapeutics.